MoneyWorks4Me

Aarti Drugs board to consider audited financial results

23 Jan 2013 Evaluate

Aarti Drugs has informed that a meeting of the board of directors of the company will be held on February 06, 2013, to consider, approve and take on record audited financial results and accounts for the quarter and nine months ended on December 31, 2012 and declaration of 2nd interim dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..